Cannabis stocks – struggling to get high

Cannabis stocks – struggling to get high
Greenfern will soon start writing clinical trial protocols for a low dose cannabidiol medication. (Image: Getty)
Brian Gaynor
The three NZX-listed cannabis companies – Cannasouth, Greenfern Industries and Rua Bioscience – are struggling to gain momentum, particularly as far as their share price performances are concerned.All three stocks are trading well below their issue price.This will be a major disappointment to Sharesies investors because they have dominated trading activity in all three companies.Sharesies investors make up 61% of all Cannasouth on-market trades by number since listing, 70.5% of Greenfern’s trades, and 64.3% of Rua Bioscience&r...

More Opinion

Why luxury needs a wake-up call
Opinion Fashion

Eden Bradfield: Why luxury needs a wake-up call

The focus should be on selling consumers a lifestyle, not just status symbols. 

Facebook is no place for risky financial investment offers
Opinion

Maria Slade: Facebook is no place for risky financial investment offers

Misleading ads continue to be thrust in the faces of Mum and Dad investors.

Maria Slade 30 Jun 2025
Money, Money, Money
Opinion

Simon Robertson: Money, Money, Money

Like it or not, everything digital is coming.

Simon Robertson 28 Jun 2025